GSK RSV vaccine (GSK3003891A)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK RSV vaccine (GSK3003891A), covering 2017-08-16 to 2017-08-16. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women [Phase 2]